首页> 外国专利> Fenilaminas cyclic Derivatives, and their salts, Pharmaceutical composition useful, useful as Beta 3 adrenergic receptor agonists to treat insulin resistance or hyperglycemiaType II diabetes, urinary incontinence, atherosclerosis, gastrointestinal disorders, neurogenetic inflammation, glaucoma, ocular hypertension.

Fenilaminas cyclic Derivatives, and their salts, Pharmaceutical composition useful, useful as Beta 3 adrenergic receptor agonists to treat insulin resistance or hyperglycemiaType II diabetes, urinary incontinence, atherosclerosis, gastrointestinal disorders, neurogenetic inflammation, glaucoma, ocular hypertension.

机译:Fenilaminas环状衍生物及其盐,有用的药物组合物,可用作β3肾上腺素能受体激动剂,用于治疗胰岛素抵抗或高血糖II型糖尿病,尿失禁,动脉粥样硬化,胃肠道疾病,神经遗传性炎症,青光眼,高眼压症。

摘要

The present Invention relates to compounds of the formula I with the structure where R1, R2, R3, R4, R5, T, T2,And x are defined in the Claims, or a pharmaceutically acceptable Salt thereof,Which are appropriate in the Treatment or inhibition of desrodenes Related Metabolic insulin resistance or hyperglycemia (typically associated with Obesity or intolerableSo the arteriosclerosis Glucose), gastrointestinal disorders, neurogenetic inflammation, glaucoma,Ocular hypertension or frequent urination and are particularly appropriate in the Treatment or inhibition of Type II diabetes.
机译:本发明涉及具有以下结构的式I化合物或其药学上可接受的盐:其中R1,R2,R3,R4,R5,T,T2和x在权利要求中定义,其适合用于治疗或抑制雄激素相关的代谢性胰岛素抵抗或高血糖症(通常与肥胖有关或难以忍受,因此导致动脉硬化性葡萄糖),胃肠道疾病,神经遗传性炎症,青光眼,高眼压或小便频繁,特别适合治疗或抑制II型糖尿病。

著录项

  • 公开/公告号CL2001001677A1

    专利类型

  • 公开/公告日2002-03-27

    原文格式PDF

  • 申请/专利权人 WYETH;

    申请/专利号CL2001001677

  • 申请日2001-07-16

  • 分类号A61P13/00;A61P27/06;A61P3/10;C07D211/56;C07D211/58;C07D223/12;C07D233/76;C07D401/10;C07D401/12;C07D401/14;C07D403/12;C07D405/12;C07D405/14;C07D409/12;C07D409/14;C07D413/14;C07D417/10;C07D417/14;

  • 国家 CL

  • 入库时间 2022-08-22 00:45:55

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号